PDS Biotechnology (PDSB) Non-Current Debt (2014 - 2025)
PDS Biotechnology (PDSB) recorded Non-Current Debt of $11.73 million in Q4 2025, up 27.5% from $9.2 million a year earlier but down 1.3% from the prior quarter.
Powered by 
Analysis
PDS Biotechnology (PDSB) Non-Current Debt (2014 - 2025) Analysis & Trends
Starting with Q4 2014, PDS Biotechnology's Non-Current Debt history includes 25 quarters.
- Annual Non-Current Debt has a three-year compound annual growth rate of -20.1% (FY2022 to FY2025).
- Across earlier years, Non-Current Debt came in at $9.2 million in FY2024 (-52.8%), $19.51 million in FY2023 (-15.3%) and $23.02 million in FY2022.
- Quarterly Non-Current Debt has ranged from $6.35 million in Q1 2025 to $23.41 million in Q3 2023 over the past five years.
- On a year-over-year basis, Non-Current Debt rose in 1 of the last eight quarters, with an average decline of 26.5%.
- Peak year-over-year performance for Non-Current Debt in the last five years was growth of 27.5% in Q4 2025, against a decline of 61.9% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $11.89 million (Q3 2025), $12.94 million (Q2 2025) and $6.35 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | PDS Biotechnology | 43.06 Mn | 43.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.73 Mn |
| Sep 30, 2025 | 11.89 Mn |
| Jun 30, 2025 | 12.94 Mn |
| Mar 31, 2025 | 6.35 Mn |
| Dec 31, 2024 | 9.20 Mn |
| Sep 30, 2024 | 12.03 Mn |
| Jun 30, 2024 | 13.81 Mn |
| Mar 31, 2024 | 16.65 Mn |
| Dec 31, 2023 | 19.51 Mn |
| Sep 30, 2023 | 23.41 Mn |
| Jun 30, 2023 | 23.25 Mn |
| Mar 31, 2023 | 23.14 Mn |
| Dec 31, 2022 | 23.02 Mn |
| Sep 30, 2022 | 22.91 Mn |
| Dec 31, 2017 | 17.38 Mn |
| Sep 30, 2017 | 14.88 Mn |
| Jun 30, 2017 | 17.13 Mn |
| Mar 31, 2017 | 14.51 Mn |
| Dec 31, 2016 | 14.95 Mn |
| Sep 30, 2016 | 14.82 Mn |
API Access
PDS Biotechnology Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=PDSB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "PDSB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=PDSB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();